首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Effect of infertility, maternal age, and number of previous miscarriages on the outcome of preimplantation genetic diagnosis for idiopathic recurrent pregnancy loss.
【24h】

Effect of infertility, maternal age, and number of previous miscarriages on the outcome of preimplantation genetic diagnosis for idiopathic recurrent pregnancy loss.

机译:不育,产妇年龄和以前的流产次数对特发性反复妊娠流产的植入前基因诊断结果的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine whether preimplantation genetic diagnosis (PGD) would decrease spontaneous abortion rates in patients with idiopathic recurrent pregnancy loss (RPL). DESIGN: Controlled clinical study. SETTING: IVF center and PGD reference laboratory. PATIENT(S): Patients with RPL with no known etiology. INTERVENTION(S): Preimplantation genetic diagnosis by fluorescence in situ hybridization analyzing nine chromosomes. MAIN OUTCOME MEASURE(S): The spontaneous abortion rate after PGD was compared to the patients' own expected risk of abortion. Patients were evaluated according to the number of previous losses, fertility, and maternal age. RESULT(S): Preimplantation genetic diagnosis significantly reduced spontaneous abortions in patients with RPL, especially for patients with more than two previous losses (12.8% vs. 35.9% expected). The PGD significantly reduced the rate of spontaneous abortion in both fertile (15.2% vs. 33.8% expected) and infertile patients (13.0% vs. 29.5%), which also achieved similar delivery rates (37% and 34%, respectively). The beneficial effect of PGD was less pronounced in patients <35 years than in patients > or =35 years old (13.6% vs. 34.0% expected). Overall, the PGD reduced the miscarriage rate to a similar baseline of 14%-16% across all maternal ages. CONCLUSION(S): Preimplantation genetic diagnosis improves pregnancy outcome for women with idiopathic RPL, especially those with more than two previous losses, and >35 years of age, and that improvement is not affected by fertility status.
机译:目的:确定植入前遗传学诊断(PGD)是否会降低特发性反复妊娠丢失(RPL)患者的自然流产率。设计:对照临床研究。地点:试管婴儿中心和PGD参考实验室。患者:病因不明的RPL患者。干预:通过荧光原位杂交分析九个染色体,进行植入前遗传学诊断。主要观察指标:将PGD术后自然流产率与患者自身预期的流产风险进行比较。根据先前的流失次数,生育力和产妇年龄对患者进行评估。结果:植入前遗传学诊断显着减少了RPL患者的自然流产,尤其是对于先前有两次以上损失的患者(分别为12.8%和35.9%的预期)。 PGD​​显着降低了可育患者(预期的15.2%比预期的33.8%)和不育患者的自然流产率(分别为13.0%和29.5%),也达到了相似的分娩率(分别为37%和34%)。在<35岁的患者中,PGD的有益作用不及在>或= 35岁的患者中显着(预期的13.6%和34.0%)。总体而言,PGD在所有孕产妇年龄中均将流产率降低至相似的基线,即14%-16%。结论:植入前遗传学诊断可改善特发性RPL妇女的妊娠结局,特别是先前有两次以上损失且年龄大于35岁的妇女,并且这种改善不受生育状况的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号